RAM
CRL icon

Ramirez Asset Management’s Charles River Laboratories CRL Stock Holding History

Ramirez Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-892
Closed -$134K – 350
2025
Q1 		$134K Hold
892
– – 0.03% 226
2024
Q4 		$165K Hold
892
– – 0.03% 214
2024
Q3 		$176K Hold
892
– – 0.03% 209
2024
Q2 		$184K Hold
892
– – 0.04% 212
2024
Q1 		$242K Hold
892
– – 0.05% 201
2023
Q4 		$211K Hold
892
– – 0.04% 219
2023
Q3 		$175K Buy
+892
New +$183K 0.04% 225

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Ramirez Asset Management's CRL Position: Q2 2025 in Review

Ramirez Asset Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 892 shares — an estimated $134K sold.

Ramirez Asset Management first reported a position in CRL in Q3 2023 and held it in 7 quarters. The position peaked at $242K in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Ramirez Asset Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Ramirez Asset Management sold 892 Charles River Laboratories shares in Q2 2025, an estimated $134K.
  • Ramirez Asset Management first reported a position in Charles River Laboratories in Q3 2023 and held it in 7 quarters.
  • Ramirez Asset Management's Charles River Laboratories position peaked at $242K in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Ramirez Asset Management's 13F filing for Q2 2025, filed 24 Jul 2025.